Skip to main content
Article
Pharmacokinetics of meloxicam in mature swine after intravenous andoral administration
Journal of Veterinary Pharmacology and Therapeutics
  • Monique D. Pairis-Garcia, Iowa State University
  • Anna Johnson, Iowa State University
  • Butch Kukanich, Kansas State University
  • Larry W. Wulf, Iowa State University
  • Suzanne T. Millman, Iowa State University
  • Kenneth J Stalder, Iowa State University
  • Locke A. Karriker, Iowa State University
  • Johann F. Coetzee, Iowa State University
Document Type
Article
Publication Version
Published Version
Publication Date
6-1-2015
DOI
10.1111/jvp.12170
Abstract

The purpose of this study was to compare the pharmacokinetics of meloxicam in mature swine after intravenous (IV) and oral (PO) administration. Six mature sows (mean bodyweight ± standard deviation = 217.3± 65.68 kg) were administered an IV or PO dose of meloxicam at a target dose of 0.5 mg/kg in a cross-over design. Plasma samples collected up to 48 hours post-administration were analyzed by high pressure liquid chromatography and mass spectrometry (HPLC-MS) followed by non-compartmental pharmacokinetic analysis. Mean peak plasma concentration (CMAX) after PO administration was 1070 ng/ml (645-1749 ng/ml). TMAX was recorded at 2.40 hour (0.50-12.00 hours) after PO administration. Half-life (T ½ λz) for IV and PO administration was 6.15 hours (4.39-7.79 hours) and 6.83 hours (5.18-9.63 hours) respectively. The bioavailability (F) for PO administration was 87% (39-351%). The results of the present study suggest that meloxicam is well absorbed after oral administration.

Comments

This is a manuscript of an article from Journal of Veterinary Pharmacology and Therapeutics 38 (2015): 265, doi:10.11 11/jvp.12170. Posted with permission.

Copyright Owner
Pairis-Garcia, M.D., et al.
Language
en
File Format
application/pdf
Citation Information
Monique D. Pairis-Garcia, Anna Johnson, Butch Kukanich, Larry W. Wulf, et al.. "Pharmacokinetics of meloxicam in mature swine after intravenous andoral administration" Journal of Veterinary Pharmacology and Therapeutics Vol. 38 Iss. 3 (2015) p. 209 - 312
Available at: http://works.bepress.com/kenneth_stalder/154/